Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

July 25, 2017

At a time when life-saving antiretrovirals are more widely available than ever, an unacceptably high number of people are still dying of AIDS in sub-Saharan Africa.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

June 27, 2017

June 02, 2016

In many contexts where Doctors Without Borders/Médecins Sans Frontières (MSF) works, key populations (also referred to as most-at-risk populations) such as sex workers and men who have sex with men have a higher risk of contracting HIV and a lower ability to access antiretroviral care due to stigma, discrimination, and their high mobility.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 17, 2016

Whitney Ward, a Doctors Without Borders/Médecins Sans Frontières (MSF) field coordinator in Malawi, explains the need for increased humanitarian assistance for over 5,000 Mozambicans who fled to Malawi's Kapise village to escape violence.

What are living conditions like in Kapise?

I’ve worked in several camps and I haven’t seen such levels of overcrowding.

December 01, 2015

Lifesaving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa, most often despite sufficient stocks already being present in countries.

November 30, 2015

Click Here to Download the Full Report

Despite considerable investments in supply chain reforms, wide-spread medicines stock outs negatively constrain patients’ ability to have access to their medication. Limited availability of antiretroviral drugs (ARVs) caused by dysfunctional supply chains impedes patient initiation and adherence and poses a major barrier to win the global fight against HIV.

Pages